Eylea intravitreal injection solution 40mg/mL, manufactured by Bayer Pharmaceutical, contains aflibercept (genetical recombination). This anti-angiogenic ophthalmic agent is used for treating various eye conditions causing vision impairment, supplied as 2mg 0.05mL 1 bottle with YJ code 1319405A1027.
Eylea intravitreal injection solution 40mg/mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →